All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Indolent B-cell lymphomas
Indolent B-cell lymphomas
This group includes indolent lymphomas, such as follicular lymphoma (FL) and marginal zone lymphoma (MZL). These have a more protracted clinical course, and many patients may not require intensive treatment in the beginning of their disease. In some patients, however, FL may transform into a more aggressive form that resembles diffuse large B-cell lymphoma (DLBCL) (FL Grade 3b).